Counselling Service for Low-income EM in Hong Kong
The Effectiveness of Counselling on Mood Symptoms of Low-income Ethnic Minorities in Hong Kong: a Wait-list Randomised Controlled Trial
This study will recruit 120 ethnic minorities in Hong Kong from the Zubin Foundation (TZF) at the Ethnic Minority Well-being Centre (EMWBC), which is a service provider of EM mental health support in Hong Kong. This service provides counselling service and referrals to HA via the Integrated Community Centre for Mental Wellness (ICCMW) to psychiatrists. The service covers the South Asians population of approximately eighty-four thousands people in Hong Kong. Participants will be recruited by the Zubin Foundation through outreach activities screening and counselling will be conducted in partnering schools and NGOs (e.g., Yan Oi Tong in Tuen Mun and Yew Chung College of Early Childhood Education in Aberdeen).
The study aims to evaluate the effectiveness of counselling service for improving mood symptoms in EM, also to assess the effectiveness of counselling service in improving psychological functioning (i.e. resilience and rumination, self-compassion, self-efficacy and life satisfaction), social functioning and quality of life and to assess whether the counselling service is cost-effective and offers good value for money.
The study is a wait-list RCT. Participants will be randomly assigned into either the intervention group (n = 60) or the wait-list control group (n = 60) in a 1:1 ratio. Each participant in the intervention group will be paired up with a participant from the control group, the number of sessions and duration of waiting period varies depending on the severity of mood symptoms. Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post
-treatment for counselling group (T1, W8), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention. Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions. Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
This evaluation study will provide data to inform the government in mental health policy review and development.
Přehled studie
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Yi Nam Suen, PhD
- Telefonní číslo: 39179579
- E-mail: suenyn@hku.hk
Studijní místa
-
-
-
Hong Kong, Hongkong
- Nábor
- University of Hong Kong
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- South Asian ethnic minorities (except domestic helper) in Hong Kong;
- 15 - 64 years
- reach at least the mild level of the Depression Anxiety Stress Scales - 21 Items in at least one of the following scores: the Depression Score (DASS-D), Anxiety Score (DASS-A) or Stress Score (DASS-S), or low Quality of Life score
- have sufficient proficiency in English, Hindi or Urdu to understand verbal instructions and give informed consent.
Exclusion Criteria:
- from high-income family (cut off ranges from HK$15K for single person family to HK$45K of 6 or more people family)
- mental conditions that require other treatment priorities (e.g., suicidal risk, substance abuse, current or past episodes of psychotic disorder, personality disorders)
- medical conditions that severely limit participation, comprehension, or adherence to treatment (e.g., epilepsy, dementia, terminal medical illness) and,
- current usage of antidepressant or mood stabilizers.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Counselling group
Counselling sessions will be conducted at the designated centers operated by the Zubin foundation.
According to the level of the DASS score, 6 to 10 sessions (based on the algorithm) of counselling service will be provided to the participants by three registered counsellors.
A lead counsellor will oversee all cases and services.
The counselling program consists of 6-10 60-minute sessions, and the sessions can be flexibly delivered over 1 to 2 weeks, ranging from one 60-minute session biweekly or weekly.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
|
Jiný: Waiting group
For participants in the waiting list control group, they will receive monitoring service over phone calls during the 8-12 weeks wait period.
Counselling service will be offered after the post-treatment assessment.
|
Participants with mild to moderate mood symptoms will receive a maximum of 6 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W8), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
Participants with severe mood symptoms will receive a maximum of 10 counselling sessions and will be assessed at baseline (T0, W1), at post-treatment for counselling group (T1, W12), and after 2 booster sessions.
Participants in the waiting list control group will receive the same counselling service after the counselling group completed the intervention.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
The change of the level of depressive symptoms
Časové okno: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Depression sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of anxiety symptoms
Časové okno: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Anxiety sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
|
The change of the level of stress symptoms
Časové okno: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Stress sub-scale of Depression, Anxiety and Stress Scale 21-item version.
The subscale has 7 items, each rated from 0 to 3, the total score will be doubled for interpretation of its severity.
The higher score indicates the more severe depressive symptoms.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
The change of subjective quality of life
Časové okno: From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Measured by the Mental Component Summary (MCS) of Short Form 12 version 2. Min: 0, max:100.
The higher score indicates better mental health related subjective quality of life.
|
From Time 0 (baseline) to Time 1 (at week 8 or 12)
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Eric Yu Hai Chen, MD, The University of Hong Kong
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- EM RCT
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .